-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$12.00445.45% Upside
Cellectar Biosciences, Inc. Frequently Asked Questions
-
What analysts cover Cellectar Biosciences, Inc.?
Cellectar Biosciences, Inc. has been rated by research analysts at Oppenheimer in the past 90 days.